Cvs Health (CVS) Receivables - Other (2017 - 2026)

Cvs Health has reported Receivables - Other for 10 years, with the latest figure at $6.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 35.85% year-over-year to $6.7 billion; the trailing twelve-month figure through Mar 2026 stood at $6.7 billion (down 35.85% YoY), and the FY2025 full-year result was $10.6 billion, up 6.9% from the prior year.
• Receivables - Other for Q1 2026 stood at $6.7 billion, down from $10.6 billion in the prior quarter.
• The five-year high for Receivables - Other was $11.9 billion in Q4 2023, with the low at $6.7 billion in Q1 2026.
• Historically, Receivables - Other has averaged $9.8 billion across 5 years, with a median of $9.9 billion in 2024.
• Annual changes were most pronounced in 2023 — Receivables - Other surged 32.56% — and 2026, when it tumbled 35.85%.
• Cvs Health's Receivables - Other stood at $9.0 billion in 2022, then surged by 32.56% to $11.9 billion in 2023, then fell by 17.02% to $9.9 billion in 2024, then climbed by 6.9% to $10.6 billion in 2025, then sank by 36.53% to $6.7 billion in 2026.
• The last three Receivables - Other figures came in at $6.7 billion (Q1 2026), $10.6 billion (Q4 2025), and $11.2 billion (Q3 2025), per Business Quant data.